Oxacillin Free Base

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 414659

CAS#: 66-79-5 (free base)

Description: Oxacillin Free Base is an antibiotic similar to FLUCLOXACILLIN used in resistant staphylococci infections.

Chemical Structure

Oxacillin Free Base
CAS# 66-79-5 (free base)

Theoretical Analysis

MedKoo Cat#: 414659
Name: Oxacillin Free Base
CAS#: 66-79-5 (free base)
Chemical Formula: C19H19N3O5S
Exact Mass: 401.1045
Molecular Weight: 401.44
Elemental Analysis: C, 56.85; H, 4.77; N, 10.47; O, 19.93; S, 7.99

Price and Availability

This product is not in stock, which may be available by custom synthesis. For cost-effective reason, minimum order is 1g (price is usually high, lead time is 2~3 months, depending on the technical challenge). Quote less than 1g will not be provided. To request quote, please email to sales @medkoo.com or click below button.
Note: Price will be listed if it is available in the future.

Request quote for custom synthesis

Related CAS #: 1173-88-2 (sodium)   66-79-5 (free base)   7240-38-2 (sodium hydrate)    

Synonym: Oxacillin Free Base; MPi-PC; MPI-penicillin; Prostaphlyn

IUPAC/Chemical Name: 4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 3,3-dimethyl-6-(((5-methyl-3-phenyl-4-isoxazolyl)carbonyl)amino)-7-oxo-, (2S-(2alpha,5alpha,6beta))-


InChi Code: InChI=1S/C19H19N3O5S/c1-9-11(12(21-27-9)10-7-5-4-6-8-10)15(23)20-13-16(24)22-14(18(25)26)19(2,3)28-17(13)22/h4-8,13-14,17H,1-3H3,(H,20,23)(H,25,26)/t13-,14+,17-/m1/s1

SMILES Code: O=C([C@@H](C(C)(C)S[C@]1([H])[C@@H]2NC(C3=C(C)ON=C3C4=CC=CC=C4)=O)N1C2=O)O

Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: To be determined

Shelf Life: >2 years if stored properly

Drug Formulation: To be determined

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.9001

Preparing Stock Solutions

The following data is based on the product molecular weight 401.44 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.


Dilution Calculator

Calculate the dilution required to prepare a stock solution.

1: Negi B, Kumar D, Kumbukgolla W, Jayaweera S, Ponnan P, Singh R, Agarwal S, Rawat DS. Anti-methicillin resistant Staphylococcus aureus activity, synergism with oxacillin and molecular docking studies of metronidazole-triazole hybrids. Eur J Med Chem. 2016 Jun 10;115:426-37. doi: 10.1016/j.ejmech.2016.03.041. Epub 2016 Mar 18. PubMed PMID: 27046397.

2: Legrand T, Vodovar D, Tournier N, Khoudour N, Hulin A. Simultaneous determination of eight β-lactam antibiotics amoxicillin, cefazolin, cefepime, cefotaxime, ceftazidime, cloxacillin, oxacillin, piperacillin in human plasma using ultra-high performance liquid chromatography with ultraviolet detection. Antimicrob Agents Chemother. 2016 May 23. pii: AAC.00176-16. [Epub ahead of print] PubMed PMID: 27216076.

3: Yoon WJ, Conley A, Herrera S, Van Dorp D, Lorelli DR. Ruptured mycotic abdominal aortic pseudoaneurysm in a patient on hemodialysis complicated with oxacillin-resistant Staphylococcus aureus bacteremia. Ann Vasc Surg. 2016 May 25. pii: S0890-5096(16)30341-7. doi: 10.1016/j.avsg.2016.01.027. [Epub ahead of print] PubMed PMID: 27236094.

4: Liu P, Xue H, Wu Z, Ma J, Zhao X. Effect of bla regulators on the susceptible phenotype and phenotypic conversion for oxacillin-susceptible mecA-positive staphylococcal isolates. J Antimicrob Chemother. 2016 May 6. pii: dkw123. [Epub ahead of print] PubMed PMID: 27154864.

5: Liu X, Zhang S, Sun B. SpoVG Regulates Cell Wall Metabolism and Oxacillin Resistance in Methicillin-Resistant Staphylococcus aureus Strain N315. Antimicrob Agents Chemother. 2016 May 23;60(6):3455-61. doi: 10.1128/AAC.00026-16. Print 2016 Jun. PubMed PMID: 27001809.

6: Viehman JA, Oleksiuk LM, Sheridan KR, Byers KE, He P, Falcione BA, Shields RK. Adverse Events Lead to Drug Discontinuation More Commonly among Patients Who Receive Nafcillin than among Those Who Receive Oxacillin. Antimicrob Agents Chemother. 2016 Apr 22;60(5):3090-5. doi: 10.1128/AAC.03122-15. Print 2016 May. PubMed PMID: 26976858.

7: Ghanwate N, Thakare P, Bhise PR, Gawande S. Colorimetric method for rapid detection of Oxacillin resistance in Staphylococcus aureus and its comparison with PCR for mec A gene. Sci Rep. 2016 Mar 10;6:23013. doi: 10.1038/srep23013. PubMed PMID: 26960268; PubMed Central PMCID: PMC4785335.

8: Wu MT, Burnham CA, Westblade LF, Dien Bard J, Lawhon SD, Wallace MA, Stanley T, Burd E, Hindler J, Humphries RM. Evaluation of Oxacillin and Cefoxitin Disk and MIC Breakpoints for Prediction of Methicillin Resistance in Human and Veterinary Isolates of Staphylococcus intermedius Group. J Clin Microbiol. 2016 Mar;54(3):535-42. doi: 10.1128/JCM.02864-15. Epub 2015 Nov 25. PubMed PMID: 26607988; PubMed Central PMCID: PMC4767974.

9: Basri DF, Sandra V. Synergistic Interaction of Methanol Extract from Canarium odontophyllum Miq. Leaf in Combination with Oxacillin against Methicillin-Resistant Staphylococcus aureus (MRSA) ATCC 33591. Int J Microbiol. 2016;2016:5249534. doi: 10.1155/2016/5249534. Epub 2016 Feb 23. PubMed PMID: 27006659; PubMed Central PMCID: PMC4781960.

10: Chovanová R, Mikulášová M, Vaverková Š. Modulation of mecA Gene Expression by Essential Oil from Salvia sclarea and Synergism with Oxacillin in Methicillin Resistant Staphylococcus epidermidis Carrying Different Types of Staphylococcal Chromosomal Cassette mec. Int J Microbiol. 2016;2016:6475837. doi: 10.1155/2016/6475837. Epub 2016 Jan 6. PubMed PMID: 26880926; PubMed Central PMCID: PMC4736799.

11: Liu X, Pai PJ, Zhang W, Hu Y, Dong X, Qian PY, Chen D, Lam H. Proteomic response of methicillin-resistant S. aureus to a synergistic antibacterial drug combination: a novel erythromycin derivative and oxacillin. Sci Rep. 2016 Jan 25;6:19841. doi: 10.1038/srep19841. PubMed PMID: 26806358; PubMed Central PMCID: PMC4726183.

12: Serna-Galvis EA, Silva-Agredo J, Giraldo AL, Flórez-Acosta OA, Torres-Palma RA. Comparative study of the effect of pharmaceutical additives on the elimination of antibiotic activity during the treatment of oxacillin in water by the photo-Fenton, TiO2-photocatalysis and electrochemical processes. Sci Total Environ. 2016 Jan 15;541:1431-8. doi: 10.1016/j.scitotenv.2015.10.029. Epub 2015 Nov 11. PubMed PMID: 26479916.

13: Kong LY, Jean A, Wong H, Semret M, Frenette C, Simor AE, Fenn S, Loo VG. Bacteremia caused by a mecA-positive oxacillin-susceptible Staphylococcus aureus strain with inducible resistance. Diagn Microbiol Infect Dis. 2015 Dec;83(4):377-8. doi: 10.1016/j.diagmicrobio.2015.09.001. Epub 2015 Sep 4. PubMed PMID: 26422086.

14: Jousselin A, Manzano C, Biette A, Reed P, Pinho MG, Rosato AE, Kelley WL, Renzoni A. The Staphylococcus aureus Chaperone PrsA Is a New Auxiliary Factor of Oxacillin Resistance Affecting Penicillin-Binding Protein 2A. Antimicrob Agents Chemother. 2015 Dec 28;60(3):1656-66. doi: 10.1128/AAC.02333-15. PubMed PMID: 26711778; PubMed Central PMCID: PMC4775990.

15: Conceição T, Coelho C, de Lencastre H, Aires-de-Sousa M. Frequent occurrence of oxacillin-susceptible mecA-positive Staphylococcus aureus (OS-MRSA) strains in two African countries. J Antimicrob Chemother. 2015 Dec;70(12):3200-4. doi: 10.1093/jac/dkv261. Epub 2015 Aug 27. PubMed PMID: 26318189.

16: Goh S, Loeffler A, Lloyd DH, Nair SP, Good L. Oxacillin sensitization of methicillin-resistant Staphylococcus aureus and methicillin-resistant Staphylococcus pseudintermedius by antisense peptide nucleic acids in vitro. BMC Microbiol. 2015 Nov 11;15:262. doi: 10.1186/s12866-015-0599-x. PubMed PMID: 26560174; PubMed Central PMCID: PMC4642645.

17: Rao SN, Rhodes NJ, Lee BJ, Scheetz MH, Hanson AP, Segreti J, Crank CW, Wang SK. Erratum for Rao et al., treatment outcomes with cefazolin versus oxacillin for deep-seated methicillin-susceptible Staphylococcus aureus bloodstream infections. Antimicrob Agents Chemother. 2015 Nov;59(11):7159. doi: 10.1128/AAC.02091-15. PubMed PMID: 26464400; PubMed Central PMCID: PMC4604403.

18: Sabat AJ, Pournaras S, Akkerboom V, Tsakris A, Grundmann H, Friedrich AW. Whole-genome analysis of an oxacillin-susceptible CC80 mecA-positive Staphylococcus aureus clinical isolate: insights into the mechanisms of cryptic methicillin resistance. J Antimicrob Chemother. 2015 Nov;70(11):2956-64. doi: 10.1093/jac/dkv210. Epub 2015 Jul 20. PubMed PMID: 26198147.

19: Tuon FF, Rocha JL, Morales HM, Sakumoto MH, Miksza KF, Pecoit-Filho R. Modulation of inflammatory mediators during treatment of cellulitis with daptomycin or vancomycin/oxacillin. Int J Antimicrob Agents. 2015 Oct;46(4):476-8. doi: 10.1016/j.ijantimicag.2015.05.018. Epub 2015 Jul 2. PubMed PMID: 26187364.

20: Teibel HM, Knoderer CA, Nichols KR. Compatibility of Vancomycin and Oxacillin During Simulated Y-Site Delivery. Hosp Pharm. 2015 Sep;50(8):710-3. doi: 10.1310/hpj5008-710. Epub 2015 Sep 16. PubMed PMID: 26823620; PubMed Central PMCID: PMC4686477.